The content is available as a PDF (4.5 MB).
. 2016 Feb 6;389(Suppl 1):1–104. doi: 10.1007/s00210-016-1213-y
Abstracts of the 82nd Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 18th Annual Meeting of the Network Clinical Pharmacology Germany (VKliPha) in cooperation with the Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V. (AGAH)
Conference
Abstracts of the 82nd Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 18th Annual Meeting of the Network Clinical Pharmacology Germany (VKliPha) in cooperation with the Arbeitsgemeinschaft für Angewandte Humanpharmakologie e.V. (AGAH)
Berlin
29th February – 03rd March 2016
Issue date 2016.
© Springer-Verlag Berlin Heidelberg 2016
This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
PMCID: PMC7100641 PMID: 26852129